Amsurg (AMSG) Tops Q2 EPS by 13c, Raises FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Piper Jaffray Raises Price Target on Amsurg (AMSG) to $82 Following 2Q EPS Beat
August 5, 2015 9:47 AM EDTPiper Jaffray reiterated an Overweight rating on AmSurg (NASDAQ: AMSG), and raised the price target to $82.00 (from $72.00), following 2Q results. Revenues increased 131% y/y to $642M, which was $29M higher than consensus of $613M. Adjusted EPS of $0.97 was $0.13 higher than consensus of $0.84.
Analyst... More
